Nav1.1 positive modulators (Boehringer-Ingelheim Pharma)

N/A

Report date: 2025/03/20 15:58:56
NME

Base Information

Drug NameNav1.1 positive modulators (Boehringer-Ingelheim Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type I alpha subunit modulators
TargetsSodium channel protein type I alpha subunit
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Pharma Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim Pharma Gmbh & Co Kg
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A